Skip to main content
. Author manuscript; available in PMC: 2015 Feb 19.
Published in final edited form as: Hum Genet. 2014 Oct 4;133(12):1513–1523. doi: 10.1007/s00439-014-1490-9

Table 5.

GWAS studies of fibroproliferative disorders with associated SNPs within chr15q21.2-22.3

Study Population Trait PUBMED ID Region Position (bp) SNPs Reported Gene(s) Risk Allele OR or beta P-Value2
Adeyemo A et al (2009)(Adeyemo et al., 2009) AAs Hypertension 19609347 15q21.3 58213414 rs1550576 ALDH1A2 NR 1.92 3x10−6
Nakashima M et al (2010)(Nakashima et al., 2010) Japanese Keloid 20711176 15q21.3 56194877 rs8032158 NEDD4 C 1.51 6x10−13
Moffatt MF et al (2010)(Moffatt et al., 2010) European Ancestry Asthma 20860503 15q22.2 61069988 rs11071559 RORA C 1.18 1x10−7
Inouye M et al (2012) European Ancestry Metabolite(Inouye et al., 2012) levels/Atherosclerosis 22916037 15q22.2 59487930 rs2306786 MYO1E, CCNB2, RNF111 NR NR 1x10−10
Inouye M et al (2012) European Ancestry Metabolite(Inouye et al., 2012) levels/Atherosclerosis 22916037 15q22.2 58471979 rs16939881 AQP9 NR NR 3x10−27
*

Data abstracted from the NHGRI GWAS catalog of published GWAS studies (https://www.genome.gov/26525384)

1

NR-not reported

2

P-Value reported in published study